These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11068219)

  • 1. Oral folate reduces plasma homocyst(e)ine levels in hemodialysis patients with cardiovascular disease.
    Stanford JL; Molina H; Phillips J; Kohlman-Trigoboff D; Moore J; Smith BM
    Cardiovasc Surg; 2000 Dec; 8(7):567-71. PubMed ID: 11068219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
    Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
    Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocyst(e)ine metabolism in hemodialysis patients treated with vitamins B6, B12 and folate.
    Henning BF; Zidek W; Riezler R; Graefe U; Tepel M
    Res Exp Med (Berl); 2001 Mar; 200(3):155-68. PubMed ID: 11426667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of usual doses of folate supplementation on elevated plasma homocyst(e)ine in hemodialysis patients: no difference between 1 and 5 mg daily.
    Spence JD; Cordy P; Kortas C; Freeman D
    Am J Nephrol; 1999; 19(3):405-10. PubMed ID: 10393379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of incremental doses of folate on homocysteine and metabolically related vitamin concentrations in nondiabetic patients on peritoneal dialysis.
    de Vecchi AF; Novembrino C; Patrosso MC; Cresseri D; Ippolito S; Rosina M; Colucci P; Lando G; Bamonti Catena F
    ASAIO J; 2003; 49(6):655-9. PubMed ID: 14655730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia.
    Manns B; Hyndman E; Burgess E; Parsons H; Schaefer J; Snyder F; Scott-Douglas N
    Kidney Int; 2001 Mar; 59(3):1103-9. PubMed ID: 11231366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
    Lee YK; Kwon YJ; Yoon JW; Oh KS; Cha DR; Cho WY; Huh K; Pyo HJ; Kim HK
    J Korean Med Sci; 1999 Apr; 14(2):193-8. PubMed ID: 10331567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
    Ducloux D; Fournier V; Rebibou JM; Bresson-Vautrin C; Gibey R; Chalopin JM
    Clin Nephrol; 1998 Apr; 49(4):232-5. PubMed ID: 9582553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?
    Kunz K; Petitjean P; Lisri M; Chantrel F; Koehl C; Wiesel ML; Cazenave JP; Moulin B; Hannedouche TP
    Nephrol Dial Transplant; 1999 Aug; 14(8):1934-42. PubMed ID: 10462274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis.
    Yoo JH; Chung CS; Kang SS
    Stroke; 1998 Dec; 29(12):2478-83. PubMed ID: 9836754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocyst(e)inaemia in children with chronic renal failure.
    Lilien M; Duran M; Van Hoeck K; Poll-The BT; Schröder C
    Nephrol Dial Transplant; 1999 Feb; 14(2):366-8. PubMed ID: 10069190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term folic acid supplementation induces variable and paradoxical changes in plasma homocyst(e)ine concentrations.
    Malinow MR; Duell PB; Williams MA; Kruger WD; Evans AA; Anderson PH; Block PC; Hess DL; Upson BM; Graf EE; Irvin-Jones A; Wang L
    Lipids; 2001; 36 Suppl():S27-32. PubMed ID: 11837988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine and C-reactive protein levels in haemodialysis patients.
    Koulouridis E; Tzilianos M; Katsarou A; Costimba I; Klonou E; Panagiotaki E; Georgalidis C; Krokida A; Delaportas N; Lachanas A; Karaliotas G; Kaliolia I
    Int Urol Nephrol; 2001; 33(2):207-15. PubMed ID: 12092633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective homocysteine-lowering vitamin B treatment in peritoneal dialysis patients.
    Righetti M; Tommasi A; Lagona C; La Rosa L; Uccellini M; Sessa A
    Perit Dial Int; 2004; 24(4):373-7. PubMed ID: 15335152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.
    Bostom AG; Shemin D; Lapane KL; Nadeau MR; Sutherland P; Chan J; Rozen R; Yoburn D; Jacques PF; Selhub J; Rosenberg IH
    Atherosclerosis; 1996 Jun; 123(1-2):193-202. PubMed ID: 8782850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
    Lentz SR; Malinow MR; Piegors DJ; Bhopatkar-Teredesai M; Faraci FM; Heistad DD
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled trial of the effect of folate supplements on homocysteine, lipids and hemorheology in end-stage renal disease.
    McGregor D; Shand B; Lynn K
    Nephron; 2000 Jul; 85(3):215-20. PubMed ID: 10867536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
    Langman LJ; Ray JG; Evrovski J; Yeo E; Cole DE
    Arch Intern Med; 2000 Apr; 160(7):961-4. PubMed ID: 10761961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial.
    Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1518-24. PubMed ID: 11297577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
    Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
    Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.